unknown
Stage
1
Investors
About
Gate Bio develops small molecule drugs called Molecular Gates that selectively block and eliminate harmful extracellular proteins by preventing their secretion, aiming to treat diseases caused by those proteins.
Explore Gate Bio's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.